Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Other Operating Expenses (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Other Operating Expenses for 16 consecutive years, with $8.4 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses fell 3.27% to $8.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $33.5 million through Dec 2025, up 13.76% year-over-year, with the annual reading at $33.5 million for FY2025, 13.76% up from the prior year.
  • Other Operating Expenses for Q4 2025 was $8.4 million at Niagen Bioscience, down from $8.8 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $8.8 million in Q3 2025, with the low at $5.9 million in Q3 2022.
  • Average Other Operating Expenses over 5 years is $7.3 million, with a median of $7.1 million recorded in 2021.
  • The sharpest move saw Other Operating Expenses soared 40.72% in 2021, then decreased 28.4% in 2022.
  • Over 5 years, Other Operating Expenses stood at $8.6 million in 2021, then fell by 28.4% to $6.2 million in 2022, then increased by 5.38% to $6.5 million in 2023, then skyrocketed by 33.68% to $8.7 million in 2024, then dropped by 3.27% to $8.4 million in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $8.4 million, $8.8 million, and $8.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.